Metraipolis › archive › dc_97239f137360

Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42643613
DOI
10.3389/fimmu.2026.1909191
License (as archived)
solo-consultazione
Archived
2026-10-16T21:43:02.013Z
SHA-256 of the archived text
8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34
Stable URL of this page
https://metraipolis.com/documento/dc_97239f137360

How to cite

Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613 — Europe PMC (en), https://europepmc.org/article/MED/42643613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97239f137360 (Metraipolis archive dc_97239f137360, sha256 8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34)
BibTeX
@misc{dc97239f137360,
  title = {Rethinking PDAC: from immunological silence to therapeutic opportunity — Europe PMC PMID:42643613},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42643613},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97239f137360; sha256 8908f1c2e34033ff62ad2fc8d20638242513bde389240674f110e8ff37baac34},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643613. Agents can read the archived copy with the MCP tool read_document.